Form 4 for KVYO Klaviyo, Inc.
Accepted 2025-11-18 00:00:00 ET · period of report 2025-11-15 · accession 0001470831-25-000337 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-11-18 | 2025-11-15+ | KVYO | Edmond Landon | CLO | C - Cnv Deriv | — | +22.5K | 390.9K | +6% | — |
| D | 2025-11-18 | 2025-11-15 | KVYO | Edmond Landon | CLO | F - Tax | $28.61 | -24.2K | 379.8K | -6% | -$692.9K |
| DM | 2025-11-18 | 2025-11-15+ | KVYO | Edmond Landon | CLO | C - Cnv Deriv | $0.00 | -22.5K | 22.5K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Series A Common Stock | 2025-11-15 | C | A | 11,426 | — | 404,010 | D | — | — | (F2) Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. |
| 2 | Common | Series A Common Stock | 2025-11-15 | F | D | 24,218 | $28.61 | 379,792 | D | — | — | |
| 3 | Common | Series A Common Stock | 2025-11-17 | C | A | 11,074 | — | 390,866 | D | — | — | (F2) Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. (F4) Consists of (i) 137,268 shares of Series A Common Stock and (ii) 253,598 unvested RSUs awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. |
| 4 | Derivative | Series B Common Stock | 2025-11-15 | C | D | 11,426 | $0.00 | 33,574 | D | — · — to — | 11,426 Series A Common Stock | (F2) Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. |
| 5 | Derivative | Series B Common Stock | 2025-11-17 | C | D | 11,074 | $0.00 | 22,500 | D | — · — to — | 11,074 Series A Common Stock | (F5) Consists of 22,500 unvested RSUs awarded under the Issuer's 2015 Stock Incentive Plan, each representing the contingent right to receive one share of Series B Common Stock upon vesting and settlement. (F2) Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. |